.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Novartis
Chubb
Dow
Baxter
Daiichi Sankyo
Colorcon
QuintilesIMS
US Army

Pharmaceutical companies with the most 'New Combination' drugs

This chart shows the companies which have received the most New Combination exclusivities in the past five years.

New Combinations are one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength.

The companies with the most New Combination drugs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot